BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32563288)

  • 1. Placebo responses in Parkinson's disease.
    Lou JS
    Int Rev Neurobiol; 2020; 153():187-211. PubMed ID: 32563288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of expectation on placebo-induced dopamine release in Parkinson disease.
    Lidstone SC; Schulzer M; Dinelle K; Mak E; Sossi V; Ruth TJ; de la Fuente-Fernández R; Phillips AG; Stoessl AJ
    Arch Gen Psychiatry; 2010 Aug; 67(8):857-65. PubMed ID: 20679593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo mechanisms and reward circuitry: clues from Parkinson's disease.
    de la Fuente-Fernández R; Schulzer M; Stoessl AJ
    Biol Psychiatry; 2004 Jul; 56(2):67-71. PubMed ID: 15231437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Great expectations: the placebo effect in Parkinson's disease.
    Lidstone SC
    Handb Exp Pharmacol; 2014; 225():139-47. PubMed ID: 25304530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Placebo effect in Parkinson's disease].
    Miwa H
    No To Shinkei; 2007 Feb; 59(2):139-46. PubMed ID: 17315755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Placebo effect in Parkinson's disease].
    Miwa H
    Brain Nerve; 2007 Feb; 59(2):139-46. PubMed ID: 17380778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocebo and lessebo effects.
    A Mestre T
    Int Rev Neurobiol; 2020; 153():121-146. PubMed ID: 32563285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going.
    Quattrone A; Barbagallo G; Cerasa A; Stoessl AJ
    Mov Disord; 2018 Aug; 33(8):1213-1227. PubMed ID: 30230624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease.
    Sacheli MA; Neva JL; Lakhani B; Murray DK; Vafai N; Shahinfard E; English C; McCormick S; Dinelle K; Neilson N; McKenzie J; Schulzer M; McKenzie DC; Appel-Cresswell S; McKeown MJ; Boyd LA; Sossi V; Stoessl AJ
    Mov Disord; 2019 Dec; 34(12):1891-1900. PubMed ID: 31584222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teaching neurons to respond to placebos.
    Benedetti F; Frisaldi E; Carlino E; Giudetti L; Pampallona A; Zibetti M; Lanotte M; Lopiano L
    J Physiol; 2016 Oct; 594(19):5647-60. PubMed ID: 26861164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation.
    Strafella AP; Ko JH; Monchi O
    Neuroimage; 2006 Jul; 31(4):1666-72. PubMed ID: 16545582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo effect and dopamine release.
    de la Fuente-Fernández R; Lidstone S; Stoessl AJ
    J Neural Transm Suppl; 2006; (70):415-8. PubMed ID: 17017561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine release in human ventral striatum and expectation of reward.
    de la Fuente-Fernández R; Phillips AG; Zamburlini M; Sossi V; Calne DB; Ruth TJ; Stoessl AJ
    Behav Brain Res; 2002 Nov; 136(2):359-63. PubMed ID: 12429397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The placebo-reward hypothesis: dopamine and the placebo effect.
    de la Fuente-Fernández R
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S72-4. PubMed ID: 20083013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The subthalamic nucleus and the placebo effect in Parkinson's disease.
    Frisaldi E; Zamfira DA; Benedetti F
    Handb Clin Neurol; 2021; 180():433-444. PubMed ID: 34225946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
    de la Fuente-Fernández R; Ruth TJ; Sossi V; Schulzer M; Calne DB; Stoessl AJ
    Science; 2001 Aug; 293(5532):1164-6. PubMed ID: 11498597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo effects in pain.
    Colloca L
    Int Rev Neurobiol; 2020; 153():167-185. PubMed ID: 32563287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biochemical bases for reward. Implications for the placebo effect.
    De La Fuente-Fernández R; Stoessl AJ
    Eval Health Prof; 2002 Dec; 25(4):387-98. PubMed ID: 12449082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions.
    Goetz CG; Wuu J; McDermott MP; Adler CH; Fahn S; Freed CR; Hauser RA; Olanow WC; Shoulson I; Tandon PK; ; Leurgans S
    Mov Disord; 2008 Apr; 23(5):690-9. PubMed ID: 18228568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.